# An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects

> **NCT02475746** · PHASE1 · WITHDRAWN · sponsor: **Pfizer**

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-06372865
- **DRUG:** itraconazole

## Key facts

- **NCT ID:** NCT02475746
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-07
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02475746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02475746, "An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02475746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*